» Articles » PMID: 37759875

Repetitive Transcranial Magnetic Stimulation (rTMS) in Post-Traumatic Stress Disorder: Study Protocol of a Nationwide Randomized Controlled Clinical Trial of Neuro-Enhanced Psychotherapy "TraumaStim"

Overview
Journal Brain Sci
Publisher MDPI
Date 2023 Sep 28
PMID 37759875
Authors
Affiliations
Soon will be listed here.
Abstract

The use of high-frequency Transcranial Magnetic Stimulation (HF-rTMS) of the right dorsolateral prefrontal cortex (DLPFC) in treating Post-traumatic Stress Disorder (PTSD) is currently regarded as a level B intervention (probable effectiveness). HF-rTMS has attracted interest as a neuromodulation therapeutic method for PTSD. Prolonged exposure and reactivation therapy are also regarded as first-line treatments for PTSD. Randomized controlled clinical studies examining the effectiveness of several HF-rTMS sessions coupled with psychotherapy have not yet been completed. In total, 102 patients with refractory PTSD will be randomly assigned (1:1) to reactivation therapy, in addition to either active HF-rTMS (20 Hz) or sham HF-rTMS, for 12 sessions in a nationwide, multicenter, double-blind controlled trial. The impact on PTSD symptoms and neurocognitive functioning will be assessed. The primary outcome is the PTSD severity score measured based on the Clinician-Administered PTSD Scale (CAPS-5) at one month. If this additional therapy is successful, it may strengthen the case for regulatory authorities to approve this additional technique of treating PTSD. Additionally, it expands the field of neurostimulation-assisted psychotherapy.

Citing Articles

Engineering and Technological Advancements in Repetitive Transcranial Magnetic Stimulation (rTMS): A Five-Year Review.

Tubbs A, Vazquez E Brain Sci. 2024; 14(11).

PMID: 39595855 PMC: 11591941. DOI: 10.3390/brainsci14111092.


Enhancing Agency in Posttraumatic Stress Disorder Therapies Through Sensorimotor Technologies.

Adrien V, Bosc N, Peccia Galletto C, Diot T, Claverie D, Reggente N J Med Internet Res. 2024; 26:e58390.

PMID: 38742989 PMC: 11250045. DOI: 10.2196/58390.

References
1.
Kessler R, Sonnega A, Bromet E, Hughes M, Nelson C . Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995; 52(12):1048-60. DOI: 10.1001/archpsyc.1995.03950240066012. View

2.
Baron-Cohen S, Wheelwright S . The empathy quotient: an investigation of adults with Asperger syndrome or high functioning autism, and normal sex differences. J Autism Dev Disord. 2004; 34(2):163-75. DOI: 10.1023/b:jadd.0000022607.19833.00. View

3.
Boggio P, Rocha M, Oliveira M, Fecteau S, Cohen R, Campanha C . Noninvasive brain stimulation with high-frequency and low-intensity repetitive transcranial magnetic stimulation treatment for posttraumatic stress disorder. J Clin Psychiatry. 2010; 71(8):992-9. PMC: 3260527. DOI: 10.4088/JCP.08m04638blu. View

4.
Bagby R, Taylor G, Parker J . The Twenty-item Toronto Alexithymia Scale--II. Convergent, discriminant, and concurrent validity. J Psychosom Res. 1994; 38(1):33-40. DOI: 10.1016/0022-3999(94)90006-x. View

5.
Cohen S, Bikson M, Badran B, George M . A visual and narrative timeline of US FDA milestones for Transcranial Magnetic Stimulation (TMS) devices. Brain Stimul. 2021; 15(1):73-75. PMC: 8864803. DOI: 10.1016/j.brs.2021.11.010. View